Arşiv logosu
  • English
  • Türkçe
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • DSpace İçeriği
  • Analiz
  • English
  • Türkçe
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Yilmaz, Zekiye" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Küçük Resim Yok
    Öğe
    Assessment of intention and hesitancy to receive a booster dose of COVID-19 vaccine among community pharmacists using a vaccine hesitancy scale
    (Springer Heidelberg, 2023) Al-taie, Anmar; Yilmaz, Zekiye
    AimTo assess the patterns regarding COVID-19 infection and vaccination, along with the intention and hesitancy towards receiving a booster dose of the COVID-19 vaccine among community pharmacists in Istanbul, Turkiye.Subject and MethodsThis was a cross-sectional, descriptive study conducted using a three-part structured validated questionnaire among community pharmacists. Vaccine hesitancy from a booster dose of the COVID-19 vaccine was assessed using the Vaccine Hesitancy Scale.ResultsA total of 145 community pharmacists were included, with a mean age of 43.22 +/- 13.3 years. Ninety-eight percent of the respondents received the COVID-19 vaccine. Most of the participants reported significant agreement to receiving a booster dose of the vaccine (91.7%, P < 0.0001). There was a statistically significant correlation between the intention to receive a booster vaccine dose and female gender (P = 0.0008), pharmacy education degree (bachelor's degree; P < 0.0001), and work experience more than 10 years (P < 0.0001).ConclusionRegardless of side effects from the previous dose, most of pharmacists who received the COVID-19 vaccine reported an intention to receive the booster dose, which generally builds trust in vaccine acceptance and undoubtedly plays a significant role in the control of the COVID-19 pandemic.
  • Küçük Resim Yok
    Öğe
    Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study
    (Wolters Kluwer Medknow Publications, 2023) Al-Taie, Anmar; Yilmaz, Zekiye; Cakiroglu, Ahmet Yigit; Candan, Gulnihal; Bildirici, Selin
    Objective: To examine the pattern of COVID-19 infection and vaccination, and to explore pregnant women's willingness and reluctance to accept a booster dose of the COVID-19 vaccine.Methods: This was a cross-sectional, descriptive study with a convenient sample size using a structured questionnaire among pregnant women attending the gynecology and obstetrics department at Acibadem Mehmet Ali Aydinlar Hospital, Istanbul, Turkiye. The Health Belief Model scale was used to assess the intention and reluctance to accept a booster dose of the COVID-19 vaccine.Results: A total of 145 participants, with a mean age of (33.5 +/- 4.8) years, and a gestational age of (30.9 +/- 7.3) weeks, were enrolled in this study. 88.8% Received full doses of the Pfizer-BioNTech vaccination. 47.8% Participants suffered from vaccine adverse effects. Health Belief Model demonstrated a significant finding of perceived susceptibility (P<0.001), perceived severity of COVID-19 complications (P<0.001), and perceived benefits regarding a booster COVID-19 vaccination (P<0.001).Conclusions: Most pregnant women who received the COVID-19 immunization express a significant intention to receive a booster dose, regardless of the adverse effects experienced from the previous doses. However, a small percentage of the study sample express hesitancy about receiving the booster dose.

| İstinye Üniversitesi | Kütüphane | Açık Bilim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


İstinye Üniversitesi, İstanbul, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim